FDA issues warning about powdered gloves

powdered gloveThe Food and Drug Administration (FDA) has issued a Recommended Warning for Surgeon’s Gloves and Patient Examination Gloves that Use Powder. This draft guidance recommends use of a warning statement on labels for powdered medical gloves, specifically surgeon’s gloves (21 CFR 878.4460) and patient examination gloves (21 CFR 880.6250) (medical gloves that use powder). The FDA says it is concerned about the potential adverse health effects from powdered medical gloves and is recommending that the labeling for medical gloves that use powder provide a warning related to those potential health effects.

FDA’s guidance documents, including this draft guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the FDA’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word “should” in FDA guidances means that something is suggested or recommended, but not required.

In 1997, the FDA issued the “Medical Glove Powder Report” discussing the potential adverse health effects of medical glove powder, along with alternatives and current market information available at that time. Adverse health events reviewed by the Medical Glove Powder Report included (a) aerosolized powder on natural rubber latex (NRL) gloves carrying allergenic proteins as a cause of respiratory allergic reactions, (b) rhinitis, conjunctivitis and dyspnea, (c) respiratory problems, (d) granuloma formation, and (e) peritoneal adhesions. Since that time, there have been more studies regarding the risks related to medical glove powder. These clinical and laboratory studies published after 1997 indicate cornstarch glove powder affects wound healing, inflammation, adhesion formation, granulomatous peritonitis, respiratory function, as well as allergic responses. The FDA has reviewed studies from clinics and hospitals that have converted completely to powder-free gloves, indicating reduction in allergy development and respiratory issues among health care workers. However, this has not been a universal finding.

Epidemiology studies comparing the economic and adverse health events in healthcare settings before and after conversion to powder-free gloves have limitations. However, the preponderance of evidence suggests that use of low protein powder-free gloves significantly reduces occupational asthma and incidence of individuals developing allergies to NRL.

The FDA is issuing this draft guidance with a recommended warning statement for powdered medical gloves, informing users of the potential adverse health effects from these devices, including foreign body reaction, formation of granulomas, and peritoneal adhesion, especially with multiple surgeries. The warning should also include information on increases in respiratory ailments, and the development of irritant dermatitis or Type IV allergy when glove powder is used on NRL gloves. In addition, the warning should state that powder used on NRL medical gloves can serve as a carrier for airborne allergenic natural rubber latex proteins. Manufacturers who choose to use a warning other than the one provided below should ensure that the labeling addresses the risks inherent to powdered gloves.

Because of the concerns related to the potential adverse health effects from use of medical gloves that use powder and to ensure compliance with section 502 of the Federal Food, Drug, and Cosmetic Act and 21 CFR 801.5, the FDA recommends that labeling for medical gloves that use powder include the following warning statement: Warning: Powdered gloves may lead to foreign body reactions and the formation of granulomas in patients. In addition, the powder used on gloves may contribute to the development of irritant dermatitis and Type IV allergy, and on latex gloves may serve as a carrier for airborne natural latex leading to sensitization of glove users.

The FDA recommends that manufacturers of powdered gloves include this change to their product labeling no later than six months after and sooner if possible.

Advertisements

About thomasdinnocenzi

Thomas D’Innocenzi is a highly accomplished, results-focused international consultant with extensive experience in global sourcing and business development worldwide to meet evolving business needs. Tom has proven ability in implementing and managing profitable global marketing and sourcing operations. He has extensive experience in international business development to accommodate rapid growth. Skilled in building top-performing teams, bench-marking performance, and developing organizations to improve efficiency, productivity, and profitability. Experienced transition leader and change agent. Tom founded Nova Advisors with the mission of providing expert Global Business Development consulting services for companies seeking to expand their market share as an independent consultant. Tom has a network of experts and advisors throughout the Asia-Pacific region and North America. His expertise includes business development, global sourcing, manufacturing, commodities, logistics, QA/QC, FDA, regulatory compliance, sustainability, and supply chain optimization. Tom is experienced in the medical device, apparel, consumer goods and technology services verticals helping companies advance their global sourcing capabilities and develop new markets through a local and sustained approach. Located in SE Asia and the United States, Tom expands market reach to drive sales. His global sourcing strategy includes directly negotiating with commodity suppliers, supply chain networks and distributors for optimal terms based on his expertise and first-hand knowledge of the players. Contact Tom to use his consulting service to increase your global market and make global sourcing profitable for you in the Asia Pacific Region and the United States. http://www.NovaAdvisors.com thomas@NovaAdvisors.com USA Direct: +1.904.479.3600 SINGAPORE: +65.6818.6396 THAILAND: +662.207.9269
This entry was posted in Business and tagged , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s